In a monumental win for patients, Roche’s Tecentriq has a big new breast cancer approval—and another piece of the I-O market all to itself.
Sun Pharma debuts its first TV ad for psoriasis treatment Ilumya as national TV campaigns become table stakes in the crowded psoriasis category.
A new ad campaign from the pharma industry's trade group weighs in on proposed changes to Medicare.
GSK's Tesaro has partnered with actor Scott Foley for the newest PSA in its initiative to raise awareness of ovarian cancer maintenance treatment.
AbbVie’s Humira was the No. 1 pharma TV ad spender again in February, swapping places with Pfizer’s anti-inflammatory drug Xeljanz.
Sanofi, which has long been pushing digital integrated diabetes efforts, updated its progress and outlined its ambitions for connected tech.
Only a few days into the job, new Gilead CEO Daniel O’Day has a key commercial position to fill: EVP of oncology.
Novartis claims J&J is "cherry-picking" stats from a head-to-head study to make Tremfya look safer than Cosentyx.
GW Pharma may be the first drugmaker to launch a cannabis-based drug in the U.S., but it's unlikely to be the last—and that's why so many are…
Drugmakers used last weekend’s American Association of Dermatology annual meeting to trumpet new psoriasis data they hoped would give them an edge.